Abstract
Multiple organ dysfunction syndrome (MODS) is characterized by the development of progressive physiological dysfunction of ≥2 organs or organ systems and is responsible for the majority of the morbidity and mortality among patients in intensive care units. The aim of the present study was to investigate the potential genes and pathways associated with MODS. The microarray dataset GSE60088 was downloaded from the Gene Expression Omnibus and used to identify differentially expressed genes (DEGs) between organ tissues (lung, liver and kidney) obtained from a murine model of MODS and healthy controls. The interactions between DEGs in lungs, liver and kidneys were revealed by Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. Furthermore, protein-protein interaction (PPI) data for DEGs were obtained from the Search Tool for the Retrieval of Interacting Genes and a PPI network was constructed. Additionally, DEGs that were common among the three organs were screened and transcription factors that regulated them were predicted using the iRegulon plugin. A total of 943, 267 and 227 DEGs were identified in lung, liver and kidney samples, respectively, between mice with MODS and healthy controls. In lung and liver samples, two pathways that were enriched with DEGs were identified and were common between lung and liver samples, including ‘cytokine-cytokine receptor interaction’ and ‘Jnk-STAT signaling pathway’, and examples of DEGs associated with these pathways include C-X-C motif chemokine ligand (Cxcl)1 and Cxcl10, and signal transducer and activator of transcription (Stat)1, respectively. Furthermore, two common pathways were identified in liver and kidney samples, which included ‘MAPK signaling pathway’ and ‘p53 signaling pathway’, and DEGs associated with these pathways included growth arrest and DNA damage-inducible α. A total of 18 DEGs were common among lung, liver and kidney tissues, including CCAAT/enhancer binding protein β (Cebpb) and olfactomedin-like 1 (Olfml1). Cebpb modulated various other DEGs, such as Cxcl1, and Olfml1 was regulated by Stat5A. These genes and pathways may serve roles in the progression of MODS and may be considered to be potential therapy targets for MODS.
Keywords: multiple organ dysfunction syndrome, differentially expressed genes, pathway, network, transcription factor
Introduction
Multiple organ dysfunction syndrome (MODS) is characterized by the development of progressive physiological dysfunction of at least two organs or organ systems that is induced by various acute physiological damages, including trauma, burns, shock and severe infection (1,2). MODS is responsible for the majority of the morbidity and mortality among patients in intensive care units (3,4). MODS primarily affects the lungs, liver, kidney and heart (3).
Multiple factors contribute to the pathological process of MODS; however, the immunoinflammatory system is considered to serve the most important role in the pathogenesis of MODS (5,6). In the early stage of MODS, abundant release of proinflammatory cytokines, including tumor necrosis factor-α and interleukin (IL)-1β, upregulates the expression of vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1, and enhances the adhesion of monocytes and T cells to endothelial cells (7,8). During later stages of MODS, damage to the endothelium activates innate inflammatory cells in the interstitial region of affected organs and parenchymal injury occurs (5). Furthermore, other factors have been reported to be closely associated with the pathogenesis of MODS. For example, mitochondrial dysfunction is implicated in organ injury through accelerated secretion of oxidants and promotion of cell death (9). Increased heme oxygenase-1 and reduced non-specific δ-aminolevulinate synthase has been reported in septic animal models of MODS (10). A recent study demonstrated that tissue fibrosis is a common pathogenic pathway that is implicated in organ injury or failure, and multiple molecules are involved in this pathway, including mitogen-activated protein kinase (MAPK), rho-associated protein kinase and transforming growth factor (TGF)-β (11).
Gene microarrays have been widely used to investigate the nosogenesis of various diseases, including psychiatric disorders, eczema, sepsis and multiple cancer types (12–16). A recent study by Gharib et al (17) focused on processes that were frequently activated in at-risk organs and identified various putative factors implicated in early MODS based on a microarray analysis. However, numerous genes associated with the progression of MODS have not yet been identified and underlying gene regulatory mechanisms remain to be elucidated. In the present study, a gene expression profile (GSE60088) submitted by Gharib et al (17). was used to identify differentially expressed genes (DEGs) in lung, liver and kidney tissues of mouse models of MODS. The functions of, and interactions between, DEGs were subsequently analyzed. Furthermore, DEGs that were common among lung, liver and kidney tissues were determined, and the transcription factors (TFs) regulating them were predicted. The results of the present study may contribute to the understanding of the molecular mechanisms underlying MODS.
Materials and methods
Affymetrix microarray data
The raw gene expression profile dataset GSE60088 was downloaded from the public Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/) (17). Microarray data were generated by the Affymetrix Mouse Genome 430 2.0 Array platform (accession no. GPL1261; Affymetrix; Thermo Fisher Scientific, Inc., Waltham, MA, USA). A total of 27 tissue samples from a murine model of sepsis-induced MODS or controls were included in the dataset, including 5 lung samples from mice with MODS, 4 healthy lung samples, 5 liver samples from mice with MODS, 3 healthy liver samples, 5 kidney samples from mice with MODS and 5 healthy kidney samples. The murine model of sepsis-induced MODS was established by exposure to a combination of mechanical ventilation and Staphylococcus aureus pneumonia (17).
CEL files and probe annotation files were downloaded from the Affymetrix database. Gene expression data from all samples were preprocessed with background correction, quantile normalization and calculation of gene expression using the robust microarray analysis algorithm of the Affy package (v1.54.0) (18) downloaded from Bioconductor (http://www.bioconductor.org/). Subsequently, annotations file org.Mm.eg.db and mouse4302.db in R language (v3.1.3) were downloaded from Bioconductor, and were used for the conversion of probe IDs to gene symbols (19,20). If one gene symbol was matched by multiple probe IDs, then the mean expression value was selected as the expression level of this gene.
Identification of DEGs
The linear models for microarray data (Limma; v3.32.2) package (21) in R language (v3.1.3) was used to identify DEGs between samples from mice with MODS and healthy lung, liver and kidney control samples. The P-value for the differential expression of each gene was calculated using an unpaired t-test and adjusted to the false discovery rate (FDR) using the Benjamini-Hochberg method (22). Only genes with FDR<0.05 and |log2fold change|≥1 were selected as DEGs. Additionally, DEGs identified in each type of tissue were clustered using gplots package (v3.5.0) in the R software (v3.1.3) (23). Ultimately, heatmaps were generated with the pheatmap (24) package in R language (v3.1.3).
Pathway enrichment analysis
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs in lung, liver and kidney samples was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/) (25). The P-value was calculated by Fisher's exact test, and P<0.05 and gene count >2 were set as the cut-off criteria.
Construction of protein-protein interaction (PPI) networks
The PPI networks of DEGs in lung, liver and kidney tissues were identified using the Search Tool for the Retrieval of Interacting Genes (STRING; http://string-db.org/) database, which integrates various known and predicted protein associations (26). A combined score >0.7 was set as the cut-off criterion. Subsequently, the PPI network was visualized by Cytoscape software (v3.3.0; http://cytoscape.org/) (27). In the network, a node represents a protein product of a gene and lines represent interactions between proteins. The degree of each node represents the number of nodes that interact with a given node. The greater the degree, the closer the connection to other nodes.
Analysis of the DEGs identified in lung, liver and kidney tissues
Upregulated and downregulated DEGs that were common among lung, liver and kidney tissues were identified using the online tool Venny (v2.0; http://bioinfogp.cnb.csic.es/tools/venny/index.html) and Venn diagrams were constructed based on the data.
Subsequently, TFs regulating DEGs in all samples were analyzed using the plugin iRegulon (v1.3) in Cytoscape (28). Minimum identity between orthologous genes was set at 0.05 and maximum FDR on motif similarity was set as 0.001. The larger the normalized enrichment score (NES) for the output, the more reliable the regulatory association. In the present study, regulatory associations with NES>5 were selected to construct the regulatory network visualized by Cytoscape.
Results
Identification of DEGs
Following data normalization, median gene expression in each sample was similar (Fig. 1), confirming that the normalized data was suitable for further analyses. Based on the cut-off criteria, a total of 943 DEGs (618 upregulated and 325 downregulated) were identified in lung samples from mice with MODS, 267 DEGs (185 upregulated and 82 downregulated) were identified in liver samples from mice with MODS and 227 DEGs (161 upregulated and 66 downregulated) were identified in kidney samples from mice with MODS. Clustering heatmaps demonstrated that samples from mice with MODS were different compared with the healthy controls (Fig. 2).
KEGG pathway enrichment analysis of DEGs
To investigate the biological functions of the identified DEGs, KEGG pathway enrichment analysis was conducted for DEGs in lung, liver and kidney samples. According to the pathway enrichment analysis, in lung samples from mice with MODS, upregulated DEGs were primarily involved in the following pathways implicated in immunity: ‘Cytokine-cytokine receptor interaction’, including C-X-C motif chemokine ligand (Cxcl)1, Cxcl10 and IL-6 DEGs; ‘toll-like receptor signaling pathway’, including Cxcl10, IL-6 and signal transducer and activator of transcription (Stat)1 DEGs; and ‘Jak-STAT signaling pathway’, including colony-stimulating factor 3, IL-6 and Stat1 DEGs. The downregulated DEGs in lung samples from mice with MODS were involved in the following pathways: ‘Metabolism of xenobiotics by cytochrome P450’, including glutathione S-transferase α2, aldehyde dehydrogenase 3 family member A1 (Aldh3A1) and cytochrome P450 family 1 subfamily A member 1 DEGs; ‘ECM-receptor interaction’, including laminin subunit α2 and collagen type IV α4 chain DEGs; and ‘histidine metabolism’, including histamine N-methyltransferase and Aldh3A1 DEGs (Table I).
Table I.
A, Pathways that upregulated DEGs in lung samples from MODS mice were enriched in | |||
---|---|---|---|
Pathway | P-value | Gene count | DEGs |
mmu04060: Cytokine-cytokine receptor interaction | 7.75×10−22 | 52 | Il17Ra, Cxcl10, Il18Rap, Cd40, Osm, Inhba, Tnfrsf9, Ccr7, Cxcl1, IL-6… |
mmu04062: Chemokine signaling pathway | 2.32×10−16 | 39 | Cxcl1, Cxcl10, Stat1, Ccr5, Cxcl13, Cxcl16, Ccr2, Jak2, Jak3, Xcl1… |
mmu04620: Toll-like receptor signaling pathway | 4.06×10−12 | 25 | Ccl3, Tnf, Cxcl10, Myd88, IL-6, Cd40, Stat1, Ripk1, Irf7, Cd14… |
mmu04621: NOD-like receptor signaling pathway | 8.60×10−11 | 19 | Cxcl1, IL-6, Tnf, Ccl2, Cxcl2, Ccl8, Nfkbia, Nlrp3, Ccl5, Ccl7… |
mmu04630: Jak-STAT signaling pathway | 7.80×10−7 | 23 | Csf3, Socs1, Pim1, Stat1, Il7R, Stat2, Csf2Rb, Jak2, Pik3R5, Jak3… |
B, Pathways that downregulated DEGs in lung samples from MODS mice were enriched in | |||
Pathway | P-value | Gene count | DEGs |
mmu00982: Drug metabolism | 5.02×10−8 | 12 | Gstm1, Gsta2, Gsta3, Cyp2D22, Adh1, Fmo1, Fmo2, Fmo3, Maob, Aldh3A1… |
mmu00980: Metabolism of xenobiotics by cytochrome P450 | 1.68×10−6 | 10 | Gstm1, Gsta2, Gsta3, Cyp2F2, Cyp1A1, Adh1, Gstt1, Ephx1, Cyp2E1, Aldh3A1 |
mmu04512: ECM-receptor interaction | 5.56×10−4 | 8 | Lama2, Col4A4, Tnxb, Npnt, Itga8, Vtn, Thbs3, Chad |
mmu05414: Dilated cardiomyopathy | 1.03×10−3 | 8 | Lama2, Actc1, Adrb1, Adcy8, Pln, Itga8, Myh7, Tnni3 |
mmu00340: Histidine metabolism | 8.94×10−3 | 4 | Hnmt, Acy3, Maob, Aldh3A1 |
DEGs, differentially expressed genes; MODS, multiple organ dysfunction syndrome. DEGs were listed in the table based on P-value and |log2 FC| value of these DEGs.
In liver samples from mice with MODS, the upregulated DEGs were primarily enriched in the following pathways: ‘Jak-STAT signaling pathway’, including Stat1 and Stat3 DEGs; ‘cytokine-cytokine receptor interaction’, including IL-17 receptor A and Cxcl10 DEGs; ‘p53 signaling pathway’, including serpin family E member 1 and growth arrest and DNA damage-inducible (Gadd)β (Gadd45B) DEGs; and ‘MAPK signaling pathway’, including Jun proto-oncogene, AP-1 transcription factor subunit (Jun) and Gadd45B DEGs. The downregulated DEGs were primarily involved in the following pathways: ‘Steroid hormone biosynthesis’, including hydroxy-∆-5-steroid dehydrogenase, 3 β- and steroid ∆-isomerase 2 (Hsd3B2) and steroid 5 α-reductase 1 (Srd5A1) DEGs; ‘nitrogen metabolism’, including carbonic anhydrase (Car)5A and Car1 DEGs; and ‘androgen and estrogen metabolism’, including Hsd3B2 and Srd5A1 DEGs (Table II).
Table II.
A, Pathways that upregulated DEGs in liver samples from MODS mice were enriched in | |||
---|---|---|---|
Pathway | P-value | Gene count | DEGs |
mmu04630: Jak-STAT signaling pathway | 1.36×10−2 | 6 | Irf9, Osmr, Socs3, Il13Ra1, Stat1, Stat3 |
mmu04060: Cytokine-cytokine receptor interaction | 2.60×10−2 | 7 | Inhbb, Cxcl1, Tnfrsf1A, Osmr, Il13Ra1, Il17Ra, Cxcl10 |
mmu04115: p53 signaling pathway | 2.67×10−2 | 4 | Rrm2, Serpine1, Gadd45B, Gadd45A |
mmu04010: MAPK signaling pathway | 3.70×10−2 | 7 | Tnfrsf1A, Jun, Pla2G12A, Fgf21, Gadd45B, Gadd45A, Dusp6 |
B, Pathways that downregulated DEGs in liver samples from MODS mice were enriched in | |||
Pathway | P-value | Gene count | DEGs |
mmu00140: Steroid hormone biosynthesis | 5.43×10−4 | 4 | Hsd3B2, Cyp7A1, Hsd3B5, Srd5A1 |
mmu00910: Nitrogen metabolism | 3.08×10−3 | 3 | Car5A, Car1, Car3 |
mmu00150: Androgen and estrogen metabolism | 6.29×10−3 | 3 | Hsd3B2, Hsd3B5, Srd5A1 |
DEGs, differentially expressed genes; MODS, multiple organ dysfunction syndrome.
In kidney samples from mice with MODS, upregulated DEGs were primarily involved in the following pathways: ‘MAPK signaling pathway’, including dual-specificity phosphatase 1 and Jun DEGs; ‘TGF-β signaling pathway’, including inhibin β B subunit and SMAD family member 1 DEGs; and ‘p53 signaling pathway’, including thrombospondin 1 and Gadd α (Gadd45A) DEGs. The downregulated DEGs were primarily implicated in ‘PPAR signaling pathway’, including uncoupling protein 1, adiponectin, C1Q and collagen domain-containing, and fatty acid-binding protein 5 DEGs, and ‘terpenoid backbone biosynthesis’, including mevalonate diphosphate decarboxylase and isopentenyl-diphosphate ∆ isomerase 1 DEGs (Table III).
Table III.
A, Pathways that upregulated DEGs in kidney samples from MODS mice were enriched in | |||
---|---|---|---|
Pathway | P-value | Gene count | DEGs |
mmu04010: MAPK signaling pathway | 8.18×10−4 | 10 | Dusp5, Fos, Dusp4, Dusp1, Jun, Nr4A1, Fgf21, Gadd45A, Myc, Ddit3 |
mmu04350: TGF-β signaling pathway | 9.34×10−3 | 5 | Inhbb, Smad1, Thbs1, Myc, Bmp6 |
mmu04115: p53 signaling pathway | 2.80×10−2 | 4 | Cdkn1A, Pmaip1, Thbs1, Gadd45A |
mmu05200: Pathways in cancer | 3.33×10−2 | 8 | Fos, Cdkn1A, IL-6, Ptgs2, Jun, Fgf21, Myc, Stat3 |
mmu04610: Complement and coagulation cascades | 3.46×10−2 | 4 | Fgg, Thbd, Fga, F3 |
B, Pathways that downregulated DEGs in kidney samples from MODS mice were enriched in | |||
Pathway | P-value | Gene count | DEGs |
mmu03320: PPAR signaling pathway | 2.75×10−2 | 3 | Ucp1, Adipoq, Fabp5 |
mmu00900: Terpenoid backbone biosynthesis | 4.54×10−2 | 2 | Mvd, Idi1 |
DEGs, differentially expressed genes; MODS, multiple organ dysfunction syndrome.
Analysis of PPI networks
To investigate the interactions between DEGs, PPI networks for the DEGs in lung, liver and kidney samples were constructed. For DEGs in lung samples from mice with MODS, the PPI network consisted of 524 nodes and 2,703 interactions (Fig. 3A). In particular, Stat1 (degree=99), IL-6 (degree=4) and Cxcl10 (degree=54) with higher degrees were identified (Table IV).
Table IV.
A, Top 20 DEG nodes with the highest degrees in the lung PPI network | |
---|---|
Node | Degree |
Stat1 | 99 |
Tnf | 71 |
IL-6 | 64 |
Ccr7 | 57 |
Cxcl10 | 54 |
Irf1 | 50 |
Mmp9 | 47 |
Irf7 | 46 |
Cxcr2 | 46 |
Gbp2 | 45 |
Ccr5 | 44 |
Ifit1 | 43 |
Ccr1 | 43 |
Ifit3 | 42 |
Ccr2 | 42 |
Oasl2 | 41 |
Cxcr6 | 41 |
Icam1 | 41 |
Oasl1 | 40 |
Tyrobp | 40 |
B, Top 20 DEG nodes with the highest degrees in the liver PPI network | |
Node | Degree |
Jun | 16 |
Stat3 | 16 |
Stat1 | 16 |
Icam1 | 12 |
Gbp2 | 11 |
Cxcl10 | 11 |
Irf9 | 10 |
Egr1 | 9 |
Cyp7a1 | 9 |
Sirt1 | 8 |
Ifit1 | 8 |
Usp18 | 8 |
Ifit3 | 8 |
Hsd3b5 | 8 |
Cyp2b10 | 8 |
Cyp3a13 | 7 |
Rsad2 | 7 |
Irgm2 | 7 |
Saa1 | 7 |
Saa2 | 7 |
C, Top 20 DEG nodes with the highest degrees in the kidney PPI network | |
Node | Degree |
Jun | 28 |
Fos | 27 |
IL-6 | 23 |
Myc | 20 |
Egr1 | 20 |
Stat3 | 17 |
Atf3 | 14 |
Sirt1 | 14 |
Ptgs2 | 14 |
Adipoq | 13 |
Cdkn1a | 12 |
Zfp36 | 11 |
Btg2 | 10 |
Hmox1 | 10 |
Cebpb | 10 |
Junb | 9 |
Egr2 | 9 |
Icam1 | 8 |
Ddit3 | 8 |
Retn | 7 |
Klf4 | 7 |
DEGs, differentially expressed genes; MODS, multiple organ dysfunction syndrome; PPI, protein-protein interaction.
A total of 99 nodes and 179 interactions were included in the PPI network of DEGs from liver samples of mice with MODS (Fig. 3B). Notably, Jun (degree=16), Stat3 (degree=16), Stat1 (degree=16) and Cxcl10 (degree=11) with higher degrees were identified (Table IV).
Analysis of DEGs in kidney samples from mice with MODS revealed that the PPI network contained 100 nodes and 229 interactions (Fig. 3C). Especially, Jun (degree=28), IL-6 (degree=23) and Stat3 (degree=17) with higher degrees were identified (Table IV).
DEGs that are common among lung, liver and kidney samples
The present study identified 17 upregulated DEGs that were common among lung, liver and kidney samples: ChaC glutathione-specific γ-glutamylcyclotransferase 1; predicted gene Gm20186; growth differentiation factor 15; lipocalin 2 (Lcn2); metallothionein (Mt)2; suppressor of cytokine signaling 3; JunB proto-oncogene, AP-1 transcription factor subunit (Junb); tribbles pseudokinase 3; CCAAT/enhancer binding protein β (Cebpb); nocturnin; methylenetetrahydrofolate dehydrogenase (NADP+ dependent)2, methenyltetrahydrofolate cyclohydrolase; Cxcl1; basic helix-loop-helix family member e40; Mt1; intercellular adhesion molecule 1; NLR family CARD domain-containing 5; and immunity-related GTPase family M member 2 (Fig. 4A). However, only 1 downregulated DEG, olfactomedin-like 1 (Olfml1), was identified in all three tissue types (Fig. 4B).
iRegulon analysis revealed that 6 TFs were predicted to regulate DEGs that were common among all three tissue types, including Cebpb (NES=8.957), Stat5a (NES=6.51), metal regulatory transcription factor 1 (NES=5.431), REL proto-oncogene, nuclear factor-κB subunit (NES=5.177), ETS variant 6 (NES=5.154) and Sp1 transcription factor (NES=5.119). Cebpb and Stat5a were indicated to modulate 10 DEGs, including Lcn2 and Cxcl1, and Olfml1, Cxcl1 and Junb, respectively (Fig. 4C).
Discussion
MODS is a major cause of morbidity and mortality among patients with acute physiological damages (3,4). In the present study, based on the analysis of the gene expression profile of mice with MODS compared with healthy controls, 943, 267 and 227 DEGs were identified in lung, liver and kidney samples, respectively. Pathway enrichment analysis of DEGs revealed that several DEGs that were common among lung and liver tissues were implicated in ‘cytokine-cytokine receptor interaction’ and the ‘Jak-STAT signaling pathway’.
Cxcl1 and Cxcl10, DEGs that were identified in lung and liver tissue, are implicated in the ‘cytokine-cytokine receptor interaction’ pathway. During the immune response in MODS, cytokine secretion is reported to cause universal endothelial injury in organs, a pathological process that results in MODS (5). Cxcl1 and Cxcl10 encode CXC subfamily inflammatory chemokines (29,30). Upon binding to CXC receptor (CXCR) 3, Cxcl10 induced the recruitment of natural killer effectors, including T cells and dendritic cells (31). During the early stages of multiple organ failure (MOF), Cxcl10 expression was significantly increased compared with the non-MOF control (32), which is consistent with the results of the present study. In the PPI network of DEGs in the lungs and liver, Cxcl10 exhibited one of the highest degrees and interacted with Cxcl1. The receptor for Cxcl1, CXCR2, is hypothesized to act as a potential therapeutic target in sepsis, and the outcomes of the disease were improved in CXCR2-knockout mice with severe sepsis (33). There is evidence indicating that a CXCR2 chemokine receptor antagonist protected mice from acute pancreatitis and lung injury (34). The above studies indicate that CXCR2 and its ligand Cxcl1 may serve a role in the immune response in sepsis and organ failure. Taken together, Cxcl1 and Cxcl10 may exert functions in the progression of MODS.
Stat1, implicated in the Jak-STAT signaling pathway, demonstrated the highest degree in the PPI network for lung and liver tissue. Stat1 encodes a protein member of the STAT family, which mediates cellular responses to cytokines and growth factors (35). Stat1 is activated by various cytokines and is associated with proinflammatory signaling and the development of inflammatory tissue damage (36). In severe acute pancreatitis with organ failure, Stat1 was reported to be activated in monocytes (37). Furthermore, the Jak-STAT signaling pathway has been reported to be implicated in heart failure through the activity of the Stat3 protein (38). In the PPI network of DEGs in the lungs and liver, Stat1 interacted with Cxcl10. Therefore, Stat1 may serve a role in the progression of MODS via regulation of the Jak-STAT signaling pathway or interaction with Cxcl10.
Two signaling pathways, MAPK and p53 pathways, were common to liver and kidney samples. The results of the present study demonstrated that the DEG Gadd45A was enriched in both pathways. Gadd45A is a p53-regulated stress response protein and its transcription is stimulated by stress-associated conditions inhibiting growth and by exposure to DNA-damaging agents (39,40). Gadd45A has been demonstrated to be highly expressed in a mouse model of lung injury (41). In addition, upregulated Gadd45A has been detected in autoimmune diseases and contributed to autoimmunity by promoting DNA demethylation in T cells (39). Gadd45A is able to activate MEK kinase 4, which results in the phosphorylation and activation of the MAPKs p38 and c-Jun N-terminal kinase during an inflammatory response (42,43). It has been reported that MAPKs are upregulated in the toll-like receptor 4-mediated progression of multi-organ failure (44). Furthermore, p53 has been demonstrated to serve a role in inflammation (45). Therefore, Gadd45Amay function in the progression of MODS through regulation of the MAPK and p53 signaling pathways.
In lung, liver and kidney samples, there were 18 common DEGs, including 17 upregulated genes and 1 downregulated gene. Among the 17 upregulated genes, Cebpb was identified as a TF and regulated multiple DEGs that were common among the three tissue types, including Cxcl1. Cebpb encodes a transcription factor that contains a basic leucine zipper domain and functions in the regulation of genes associated with immune and inflammatory responses (46). It has been demonstrated that Cebpb in the lung epithelium contributed to lipopolysaccharide-induced Cxcl1 expression. There is no direct evidence to confirm a role for Cebpb in MODS. Therefore, the present study hypothesized that Cebpb may serve a role in the progression of MODS as a TF regulating the expression of Cxcl1 and other genes.
Additionally, in the three organs analyzed in the present study, the only common downregulated gene, Olfml1, is a glycoprotein containing the olfectamine domain. In neural tissues, olfactomedin was associated with the growth and differentiation of chemosensory cilia (47). To the best of our knowledge, an association between Olfml1 and MODS has not been previously reported. In the present study, Olfml1 was regulated by Stat5a, a member of the STAT family transcription factors. Stat5a functions in immunity by regulating the development and maintenance of T regulatory cells (48–50). Therefore, Olfml1 may be implicated in the progression of MODS through regulation by Stat5a.
There were several limitations of the present study. The predicted results should be confirmed by laboratory data. Furthermore, in the present study, a limited number of samples were used, which should be increased to improve the reliability of the conclusions drawn. In future studies, a higher number of organ samples from mice with MODS will be included to validate the expression levels of potentially implicated genes and to elucidate their functions.
In conclusion, 943, 267 and 227 DEGs were identified in lung, liver and kidney samples from mice with MODS, respectively, compared with the normal healthy controls. Certain DEGs were implicated in pathways that were common to both lung and liver samples, including ‘cytokine-cytokine receptor interaction’ (such as Cxcl1 and Cxcl10) and the ‘Jak-STAT signaling pathway’ (such as Stat1). In addition, several DEGs, including Gadd45A, were common to two signaling pathways in liver and kidney samples. Furthermore, 18 DEGs were common to all three types of tissues analyzed in the present study, including Cebpb and Olfml1. Cebpb regulated multiple DEGs, such as Cxcl1, and Stat5a regulated the expression of Olfml1. The genes and pathways identified in the present study may be implicated in the progression of MODS. Therefore, the results of the present study may provide potential therapy targets for the treatments of MODS.
Acknowledgements
The present study was supported by the Scientific and Technological Project in the Social Development Area of Science and Technology Department of Shaanxi Province (grant no. 2012K16-12-02).
References
- 1.Volman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: Experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock. 2005;23:291–297. doi: 10.1097/01.shk.0000155350.95435.28. [DOI] [PubMed] [Google Scholar]
- 2.Henao FJ, Daes JE, Dennis RJ. Risk factors for multiorgan failure: A case-control study. J Trauma. 1991;31:74–80. doi: 10.1097/00005373-199101000-00014. [DOI] [PubMed] [Google Scholar]
- 3.Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992;216:117–134. doi: 10.1097/00000658-199208000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Marshall JC. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 2001;29(7 Suppl):S99–S106. doi: 10.1097/00003246-200107001-00032. [DOI] [PubMed] [Google Scholar]
- 5.Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med. 2008;26:711–715. doi: 10.1016/j.ajem.2007.10.031. [DOI] [PubMed] [Google Scholar]
- 6.Gustot T. Multiple organ failure in sepsis: Prognosis and role of systemic inflammatory response. Curr Opin Crit Care. 2011;17:153–159. doi: 10.1097/MCC.0b013e328344b446. [DOI] [PubMed] [Google Scholar]
- 7.Henninger DD, Panés J, Eppihimer M, Russell J, Gerritsen M, Anderson DC, Granger DN. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol. 1997;158:1825–1832. [PubMed] [Google Scholar]
- 8.Bratt J, Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol. 1997;159:912–918. [PubMed] [Google Scholar]
- 9.Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion. 2004;4:729–741. doi: 10.1016/j.mito.2004.07.023. [DOI] [PubMed] [Google Scholar]
- 10.Suzuki T, Takahashi T, Yamasaki A, Fujiwara T, Hirakawa M, Akagi R. Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Biochem Pharmacol. 2000;60:275–283. doi: 10.1016/S0006-2952(00)00324-5. [DOI] [PubMed] [Google Scholar]
- 11.Rockey DC, Bell PD, Hill JA. Fibrosis-a common pathway to organ injury and failure. N Engl J Med. 2015;372:1138–1149. doi: 10.1056/NEJMra1300575. [DOI] [PubMed] [Google Scholar]
- 12.Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, Choudary PV, Myers RM, Jones EG, Watson SJ, Akil H. Microarray technology: A review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry. 2003;160:657–666. doi: 10.1176/appi.ajp.160.4.657. [DOI] [PubMed] [Google Scholar]
- 13.Nylund L, Satokari R, Nikkilä J, Rajilić-Stojanović M, Kalliomäki M, Isolauri E, Salminen S, De Vos WM. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol. 2013;13:12. doi: 10.1186/1471-2180-13-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Maslove DM, Wong HR. Gene expression profiling in sepsis: Timing, tissue, and translational considerations. Trends Mol Med. 2014;20:204–213. doi: 10.1016/j.molmed.2014.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73:1180–1189. doi: 10.1158/0008-5472.CAN-12-2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Di Narzo AF, Tejpar S, Rossi S, Yan P, Popovici V, Wirapati P, Budinska E, Xie T, Estrella H, Pavlicek A, et al. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data. J Natl Cancer Inst. 2014;106 doi: 10.1093/jnci/dju247. pii: dju247. [DOI] [PubMed] [Google Scholar]
- 17.Gharib SA, Mar D, Bomsztyk K, Denisenko O, Dhanireddy S, Liles WC, Altemeier WA. System-wide mapping of activated circuitry in experimental systemic inflammatory response syndrome. Shock. 2016;45:148–156. doi: 10.1097/SHK.0000000000000507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–315. doi: 10.1093/bioinformatics/btg405. [DOI] [PubMed] [Google Scholar]
- 19.Carlson M, Falcon S, Pages H, Li N. org. Mm. eg. db: Genome wide annotation for Mouse. org. Mm. eg. db: Genome wide annotation for Mouse. R package version. 2012 [Google Scholar]
- 20.Carlson M. Mouse4302.db: Affymetrix Mouse genome 430 2.0 array annotation data (chip mouse4302) R package. 2016 version 3.1.3. [Google Scholar]
- 21.Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, editors. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Springer; New York, NY: 2005. pp. 397–420. [DOI] [Google Scholar]
- 22.Glueck DH, Mandel J, Karimpour-Fard A, Hunter L, Muller KE. Exact calculations of average power for the Benjamini-Hochberg procedure. Int J Biostat. 2008;4 doi: 10.2202/1557-4679.1103. Article 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A, Lumley T, Maechler M, Magnusson A, Moeller S, et al. gplots: Various R programming tools for plotting data. R package. 2009 version 2. [Google Scholar]
- 24.Kolde R. https://cran.r-project.org/web/packages/pheatmap/pheatmap.pdf. [Dec 11;2015 ];Pretty heatmaps. 2015 [Google Scholar]
- 25.Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:R183. doi: 10.1186/gb-2007-8-9-r183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–D452. doi: 10.1093/nar/gku1003. (Database Issue) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kohl M, Wiese S, Warscheid B. Cytoscape: Software for visualization and analysis of biological networks. Methods Mol Biol. 2011;696:291–303. doi: 10.1007/978-1-60761-987-1_18. [DOI] [PubMed] [Google Scholar]
- 28.Janky R, Verfaillie A, Imrichová H, Van de Sande B, Standaert L, Christiaens V, Hulselmans G, Herten K, Sanchez Naval M, Potier D, et al. iRegulon: From a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol. 2014;10:e1003731. doi: 10.1371/journal.pcbi.1003731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD. The CXCR3 binding chemokine IP-10/CXCL10: Structure and receptor interactions. Biochemistry. 2002;41:10418–10425. doi: 10.1021/bi026020q. [DOI] [PubMed] [Google Scholar]
- 30.Haskill S, Peace A, Morris J, Sporn SA, Anisowicz A, Lee SW, Smith T, Martin G, Ralph P, Sager R. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci USA. 1990;87:7732–7736. doi: 10.1073/pnas.87.19.7732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Panzer U, Steinmetz OM, Paust HJ, Meyer-Schwesinger C, Peters A, Turner JE, Zahner G, Heymann F, Kurts C, Hopfer H, et al. Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol. 2007;18:2071–2084. doi: 10.1681/ASN.2006111237. [DOI] [PubMed] [Google Scholar]
- 32.Jastrow KM, III, Gonzalez EA, McGuire MF, Suliburk JW, Kozar RA, Iyengar S, Motschall DA, McKinley BA, Moore FA, Mercer DW. Early cytokine production risk stratifies trauma patients for multiple organ failure. J Am Coll Surg. 2009;209:320–331. doi: 10.1016/j.jamcollsurg.2009.05.002. [DOI] [PubMed] [Google Scholar]
- 33.Robertson CM, Coopersmith CM. The systemic inflammatory response syndrome. Microbes Infect. 2006;8:1382–1389. doi: 10.1016/j.micinf.2005.12.016. [DOI] [PubMed] [Google Scholar]
- 34.Bhatia M, Hegde A. Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury. Regul Pept. 2007;138:40–48. doi: 10.1016/j.regpep.2006.08.006. [DOI] [PubMed] [Google Scholar]
- 35.Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, Ihle JN. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J Biol Chem. 1995;270:20775–20780. doi: 10.1074/jbc.270.35.20775. [DOI] [PubMed] [Google Scholar]
- 36.Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996;84:443–450. doi: 10.1016/S0092-8674(00)81289-1. [DOI] [PubMed] [Google Scholar]
- 37.Oiva J, Mustonen H, Kylänpää ML, Kyhälä L, Alanärä T, Aittomäki S, Siitonen S, Kemppainen E, Puolakkainen P, Repo H. Patients with acute pancreatitis complicated by organ failure show highly aberrant monocyte signaling profiles assessed by phospho-specific flow cytometry. Crit Care Med. 2010;38:1702–1708. doi: 10.1097/CCM.0b013e3181e7161c. [DOI] [PubMed] [Google Scholar]
- 38.Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: From protection to failure. Pharmacol Ther. 2008;120:172–185. doi: 10.1016/j.pharmthera.2008.08.002. [DOI] [PubMed] [Google Scholar]
- 39.Li Y, Zhao M, Yin H, Gao F, Wu X, Luo Y, Zhao S, Zhang X, Su Y, Hu N, et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 2010;62:1438–1447. doi: 10.1002/art.27363. [DOI] [PubMed] [Google Scholar]
- 40.Zhan Q. Gadd45a, a p53-and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat Res. 2005;569:133–143. doi: 10.1016/j.mrfmmm.2004.06.055. [DOI] [PubMed] [Google Scholar]
- 41.Altemeier WA, Matute-Bello G, Gharib SA, Glenny RW, Martin TR, Liles WC. Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation. J Immunol. 2005;175:3369–3376. doi: 10.4049/jimmunol.175.5.3369. [DOI] [PubMed] [Google Scholar]
- 42.Uhlig U, Haitsma JJ, Goldmann T, Poelma DL, Lachmann B, Uhlig S. Ventilation-induced activation of the mitogen-activated protein kinase pathway. Eur Respir J. 2002;20:946–956. doi: 10.1183/09031936.02.01612001. [DOI] [PubMed] [Google Scholar]
- 43.Li LF, Yu L, Quinn DA. Ventilation-induced neutrophil infiltration depends on c-Jun N-terminal kinase. Am J Respir Crit Care Med. 2004;169:518–524. doi: 10.1164/rccm.200305-660OC. [DOI] [PubMed] [Google Scholar]
- 44.McGhan LJ, Jaroszewski DE. The role of toll-like receptor-4 in the development of multi-organ failure following traumatic haemorrhagic shock and resuscitation. Injury. 2012;43:129–136. doi: 10.1016/j.injury.2011.05.032. [DOI] [PubMed] [Google Scholar]
- 45.Cooks T, Harris CC, Oren M. Caught in the cross fire: p53 in inflammation. Carcinogenesis. 2014;35:1680–1690. doi: 10.1093/carcin/bgu134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Wang W, Bergh A, Damber JE. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: Relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. Prostate. 2007;67:1238–1246. doi: 10.1002/pros.20595. [DOI] [PubMed] [Google Scholar]
- 47.Bal RS, Anholt RR. Formation of the extracellular mucous matrix of olfactory neuroepithelium: Identification of partially glycosylated and nonglycosylated precursors of olfactomedin. Biochemistry. 1993;32:1047–1053. doi: 10.1021/bi00055a008. [DOI] [PubMed] [Google Scholar]
- 48.Takatori H, Nakajima H, Kagami S, Hirose K, Suto A, Suzuki K, Kubo M, Yoshimura A, Saito Y, Iwamoto I. Stat5a inhibits IL-12-induced Th1 cell differentiation through the induction of suppressor of cytokine signaling 3 expression. J Immunol. 2005;174:4105–4112. doi: 10.4049/jimmunol.174.7.4105. [DOI] [PubMed] [Google Scholar]
- 49.Takatori H, Nakajima H, Hirose K, Kagami S, Tamachi T, Suto A, Suzuki K, Saito Y, Iwamoto I. Indispensable role of Stat5a in Stat6-independent Th2 cell differentiation and allergic airway inflammation. J Immunol. 2005;174:3734–3740. doi: 10.4049/jimmunol.174.6.3734. [DOI] [PubMed] [Google Scholar]
- 50.Wei L, Laurence A, O'Shea JJ. New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin Cell Dev Biol. 2008;19:394–400. doi: 10.1016/j.semcdb.2008.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]